title: Intrathecal trastuzumab and thiotepa for leptomeningeal spread of breast cancer.
authors.forename: C
authors.initials: C
authors.lastname: Ferrario
authors.forename: A
authors.initials: A
authors.lastname: Davidson
authors.forename: N
authors.initials: N
authors.lastname: Bouganim
authors.forename: R
authors.initials: R
authors.lastname: Aloyz
authors.forename: L C
authors.initials: LC
authors.lastname: Panasci
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008279:Magnetic Resonance Imaging; D008577:Meningeal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D013852:Thiotepa / Q000008:administration & dosage; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D013852:Thiotepa; D000068878:Trastuzumab